VCM
EW icon

Verde Capital Management’s Edwards Lifesciences EW Stock Holding History

Verde Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,730
Closed -$233K – 73
2025
Q4 		$233K Hold
2,730
– – 0.05% 66
2025
Q3 		$212K Hold
2,730
– – 0.05% 66
2025
Q2 		$214K Buy
+2,730
New +$204K 0.05% 64
2025
Q1 		– Sell
-2,730
Closed -$202K – 66
2024
Q4 		$202K Buy
+2,730
New +$191K 0.06% 63

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Verde Capital Management's EW Position: Q1 2026 in Review

Verde Capital Management sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 2,730 shares — an estimated $233K sold.

Verde Capital Management first reported a position in EW in Q4 2024 and held it in 4 quarters. The position peaked at $233K in Q4 2025. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Verde Capital Management reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • Verde Capital Management sold 2,730 Edwards Lifesciences shares in Q1 2026, an estimated $233K.
  • Verde Capital Management first reported a position in Edwards Lifesciences in Q4 2024 and held it in 4 quarters.
  • Verde Capital Management's Edwards Lifesciences position peaked at $233K in Q4 2025.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Verde Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.